Ashley M. Kroon Van Diest, Scott W. Powers November 17, 2018

Purpose of Review

To highlight current evidence supporting the prescription of cognitive behavioral therapy (CBT) as part of first‐line preventive treatment for children and adolescents with headache and discuss a research strategy aimed at: (1) understanding how and why CBT works, and (2) developing effective and efficient approaches for integrating CBT into headache specialty, neurology, and primary care settings.… Read More...

Yinglu Liu, Sulei Li, Rongfei Wang, Xun Han, Min Su, Xiutang Cao, Guangyi Wang, Feng Cao, Shengyuan Yu November 17, 2018

Objective

To investigate the association between congenital heart defects (CHDs) and migraine and evaluate the efficacy of transcatheter defect closure from a new perspective.

Methods

The patients with CHDs who underwent transcatheter defect closure were screened in the medical database of Chinese PLA General Hospital from January 2006 to January 2017.… Read More...

Delphine Taussig November 17, 2018

Epilepsy surgery was first described by Horsley [1]. In Montreal in 1937, Penfield and Jasper began performing acute intraoperative electrocorticography in awake patients combined with electrical stimulations in the same step as the surgical treatment [2]. The tailored resection relied on interictal epileptiform abnormalities and on the rare recorded seizures.… Read More...

Jonathan Dallas, Dario J. Englot, Robert P. Naftel November 17, 2018

Epilepsy is one of the most common neurological conditions seen in pediatric patients. While a majority of cases are effectively treated with anti-epileptic medications (AEDs), roughly one-third of patients will remain refractory to medical treatment[1–3]. Failure to appropriately address seizures in children can result in further negative outcomes, including bodily injury and negative psychosocial sequalae[2].… Read More...

Atsushi Fujita, Hiroyasu Tsukaguchi, Eriko Koshimizu, Hitoshi Nakazato, Kyoko Itoh, Shohei Kuraoka, Yoshihiro Komohara, Masaaki Shiina, Shohei Nakamura, Mika Kitajima, Yoshinori Tsurusaki, Satoko Miyatake, Kazuhiro Ogata, Kazumoto Iijima, Naomichi Matsumoto, Noriko Miyake November 16, 2018

Objective

Galloway–Mowat syndrome (GAMOS) is a neural and renal disorder, characterized by microcephaly, brain anomalies, and early‐onset nephrotic syndrome. Biallelic mutations in WDR73 and the four subunit genes of the KEOPS complex are reported to cause GAMOS. Furthermore, an identical homozygous NUP107 (nucleoporin 107 kDa) mutation was identified in four GAMOS‐like families, although biallelic NUP107 mutations were originally identified in steroid‐resistant nephrotic syndrome.… Read More...

Andoird App
Loading...